Europe Must Act Fast or Risk Losing Out, Norway’s $2 Trillion Wealth Fund CEO Warns
Norway’s Wealth Fund CEO Issues Stark Warning Nicolai Tangen, the CEO of Norway’s sovereign wealth fund, has urged urgent reform
Novo Nordisk Faces Turbulent Board Shakeup as Weight-Loss Drug Market Pressures Intensify
Novo Nordisk Shareholders Approve Major Board Overhaul Novo Nordisk has entered a decisive new chapter after shareholders approved a sweeping